Medis Technologies Schedules Year End Financial Results Conference Call

NEW YORK, March 24, 2009 (GLOBE NEWSWIRE) -- Medis Technologies Ltd.
(Nasdaq:MDTL) ("Medis") today announced it is scheduled to issue its financial
results for the fourth quarter and year ended December 31, 2008 prior to the
opening of the stock market on Tuesday, March 31, 2009. Management will also
conduct a conference call later that morning at 11:00 a.m. Eastern Time to
review these results and discuss its business operations.

Interested parties may participate in the call by dialing 303-262-2053
approximately 10 minutes before the call is scheduled to begin and ask to be
connected to the Medis conference call. The conference call will also be
simultaneously broadcast over the Internet. A recorded replay of the conference
call will be available until 12:00 a.m. Eastern Time on April 7, 2009. Listeners
may dial 303-590-3000 and use the code 11128468 for the replay.

To listen to the live webcast, please go to www.medistechnologies.com and click
on the conference call link. The conference call will be archived and accessible
for approximately 30 days if you are unable to listen to the live call.

Schedule this webcast into MS-Outlook calendar (click open when prompted):

http://apps.shareholder.com/PNWOutlook/t.aspx?m=36032&k=97028E85

Medis Technologies' (Nasdaq:MDTL) (www.medistechnologies.com) is the creator of
the first portable fuel cell generator. The company's first generation of
products, Medis 24/7 Xtreme Portable Power Solution and the Medis Fuel Cell
Power Emergency Kit are available at Amazon.com and the FuelCellStore.com. The
portable fuel cells can provide up to 90 hours of "green" energy to power
personal electronics (i.e. cell phones, MP3 players, flashlights, etc.) anywhere
without the need for a wall socket or any external electricity source. Medis'
indirect majority-owned subsidiary, Cell Kinetics Ltd., is engaged in the
development and commercialization of the CKChip, a unique cell carrier platform
intended for simultaneous fluoroscopic monitoring and analysis of thousands of
individual living cells over time.

This press release may contain forward-looking statements, which are made
pursuant to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. In some cases you can identify those so-called
"forward-looking statements" by words such as "may," "will," "should,"
"expects," "plans," "targets," "believes," "anticipates," "estimates,"
"predicts," "potential," or "continue" or the negative of those words and other
comparable words. These forward-looking statements are subject to risks and
uncertainties, product tests, commercialization risks, availability of financing
and results of financing efforts that could cause actual results to differ
materially from historical results or those anticipated. Further information
regarding these and other risks is described from time to time in the Company's
filings with the SEC. We assume no obligation to update or alter our
forward-looking statements made in this release or in any periodic report filed
by us under the Securities Exchange Act of 1934 or any other document, whether
as a result of new information, future events or otherwise, except as otherwise
required by applicable federal securities laws.

MDTL

-0-
CONTACT: Medis Technologies Ltd.
Omer Masud, Sr. VP - IR/PR and Strategy
(212) 935-8484
General Information
Danielle DeVoren
(212) 445-8188